Commentary on the "Co-Crystal of Tramadol-Celecoxib in Patients with Moderate to Severe Acute Post-Surgical Oral Pain: A Dose-Finding, Randomised, Double-Blind, Placebo- and Active-Controlled, Multicentre Phase II Trial". Implications for Cardiovascular Safety

Abstract

Page 1 of 3 Commentary on the “Co-Crystal of Tramadol-Celecoxib in Patients with Moderate to Severe Acute Post-Surgical Oral Pain: A DoseFinding, Randomised, Double-Blind, Placeboand Active-Controlled, Multicentre Phase II Trial”. Implications for Cardiovascular Safety Sebastián Videla1*, Neus Gascón2, Carlos Plata-Salamán2 1Clinical Research Support Unit, Clinical Pharmacology Department, Bellvitge University Hospital/IDIBELL, Barcelona, Spain. 2Medical Sciences Area, ESTEVE Pharmaceuticals S.A., Barcelona, Spain.